Pearls and Prep

Medication Adherence in Psychiatry: Why Half Your Patients Aren't Taking Their Meds — and What You Can Do About It

💎 Try Boss Pearl FREE for 7 days — the full library: every deep dive, the Diagnosing curriculum, and both books free the moment you're in — so you're ready for that first patient, not just studied for it. Then $20/month, cancel anytime: https://www.patreon.com/checkout/pearlsandprep?rid=29362056 🎁 Join as a free member to access 50 Pearls from Pearls & Prep — 50 super high-yield pearls to sharpen your practice. 📚 Members get both books free — Board Bombs: PMHNP 250 Questions ($49.99) and the 100 Psychiatric Interview Tips E-Book ($39.99). Not a member yet? Both are in the shop: https://www.patreon.com/c/pearlsandprep/shop ⭐ Enjoying the show? Please rate and review Pearls and Prep on Apple Podcasts or Spotify — it really helps! 🌐 PearlsandPrep.com — scan this episode's Street Takes card, read the deep-dive articles, and unlock the full clinical library: https://pearlsandprep.com ✉️ Questions or a case you want covered? Write to NP Z: pearlsandpreppodcast@gmail.com You picked the perfect medication. The dose is right, the diagnosis is right — and the patient quietly stops taking it. In this bonus episode, NP Z goes on a pearl dive into the most under-appreciated number in psychiatry: up to half of patients with major psychiatric disorders do not take their medications as prescribed — 56% in schizophrenia, 50% in major depression, 44% in bipolar disorder. The stakes are relapse, hospitalization, suicide risk, and worse — and the fix starts in your very first conversation with the patient. 📊 Pearl 1 — The number itself. A 2020 meta-analysis of 35 studies found overall psychotropic non-adherence of 49%: schizophrenia 56%, major depressive disorder 50%, bipolar disorder 44%. And the patients in your office are under-reporting it — nobody wants to disappoint you. Assume the real number in your panel is at least this high. ⚠️ Pearl 2 — The stakes are not abstract. Non-adherence drives relapse in schizophrenia, sharply higher hospitalization rates, violence, arrest, substance use, homelessness, and early death. The lithium lesson is the starkest: in the classic discontinuation studies, suicidal behavior rose roughly 20-fold in the first year after lithium was stopped — and abrupt stopping was about twice as dangerous as a slow taper. Even short gaps matter. 🎯 Pearl 3 — Ask about deal-breakers before they happen. The top reasons patients stop are side effects: weight gain, sedation, sexual dysfunction, akathisia/EPS, and cognitive dulling. Ask every patient, up front: "What are your deal-breaker side effects? What will you not tolerate?" A medication the patient won't take is never the best medication — no matter how perfect it looks on paper. 🧠 Pearl 4 — Explore what the medication means to them. Patients quietly believe a higher dose means they are "more mentally ill," fear they'll be on medication for life, and carry real stigma about it. Sometimes the dose is higher simply because they metabolize the drug faster. Name that out loud — and give the patient agency: "You've been taking your mental health seriously." Credit their commitment, not just the molecule. 🛠️ Pearl 5 — Treat side effects like symptoms, and simplify. Side effects torpedo a treatment plan exactly the way symptoms do, so manage them just as aggressively: consider metformin for antipsychotic weight gain (still strikingly underused), lower the dose, augment, or switch — always with the patient's values in the lead. And keep the regimen simple: forgetting is one of the most common reasons for non-adherence, so build in pill organizers, reminders, and habit stacking — pills beside the toothbrush, the midday dose in the lunch bag. 📖 Sources & further reading: • Semahegn A, Torpey K, Manu A, Assefa N, Tesfaye G, Ankomah A. Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis. Systematic Reviews. 2020;9:17. (The episode's headline figures: 49% overall non-adherence; schizophrenia 56%, major depressive disorder 50%, bipolar disorder 44%.) Read the full text free here: https://pmc.ncbi.nlm.nih.gov/articles/PMC6966860/ • Baldessarini RJ, Tondo L, Hennen J. Effects of lithium treatment and its discontinuation on suicidal behavior in bipolar manic-depressive disorders. Journal of Clinical Psychiatry. 1999;60(Suppl 2):77–84. (Suicidal rates rose ~20-fold in the first year after lithium discontinuation; fatalities ~14× more frequent after discontinuation; risk about 2-fold lower after slow versus rapid discontinuation.) • World Health Organization. Adherence to Long-Term Therapies: Evidence for Action. Geneva: WHO; 2003. (The shared-plan definition of adherence NP Z cites: the degree to which a person's behavior corresponds with agreed recommendations from a healthcare provider.) • Velligan DI, Weiden PJ, Sajatovic M, et al. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. Journal of Clinical Psychiatry. 2009;70(Suppl 4):4–48. (Consequences of non-adherence in serious mental illness — relapse, rehospitalization, suicidality, homelessness, criminal-justice involvement — and the ≥80%-of-doses threshold commonly used to define adherence.) 🎧 Pearls & Prep — new episodes every Tuesday. Hosted by NP Z, Duke-trained Psychiatric Nurse Practitioner. ⚖️ Disclaimer: Pearls and Prep is an educational podcast and is not medical advice. All views expressed are exclusively those of NP Z and do not represent — and are not endorsed by — any other entity or organization. These perspectives are offered solely to build conceptual appreciation of psychiatric topics; they are not a substitute for clinical judgment, current clinical guidelines, or primary references. Always use appropriate resources and your own clinical judgment when making decisions about individual patients. Nothing in this episode creates a clinician–patient relationship. 🎓 NP Z's Most Recommended Resources — Pass Your Boards & See Your First Patient The exact shelf behind this podcast: the textbooks open on NP Z's desk, and his own BOARD BOMBS™ + Interview Tips. 👉 pearlsandprep.com/resources Your board date is already on the calendar, and your first patient is already on someone's schedule. Build the shelf they're both counting on — start today.

The 2-Week Rule: Schizoaffective Disorder Made Easy

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep Schizoaffective disorder can get confusing fast. Is it schizophrenia, bipolar disorder, major depression with psychotic features—or schizoaffective disorder? In this episode of Pearls and Prep, NPZ makes the diagnosis simple by breaking down the psychosis timeline, the famous 2-week rule, bipolar vs depressive subtype, and how to distinguish schizoaffective disorder from MDD or bipolar disorder with psychotic features. We also cover practical treatment pearls, including antipsychotics, mood stabilizers, long-acting injectables, adherence, substance-use screening, psychoeducation, and why collateral history matters so much when the timeline gets messy. Perfect for PMHNP students, psychiatric nurse practitioners, NP boards, psych pharmacology review, and clinicians who want schizoaffective disorder explained in plain English. 38 The 2-Week Rule: Schizoaffective Disorder Made Easy Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

• Transcript

Lamictal (Lamotrigine): 4 Things You Need to Know — the Rash, the Titration, the Restart Rule & Why Patients Stay on It

💎 Try Boss Pearl FREE for 7 days — the full library: every deep dive, the Diagnosing curriculum, and both books free the moment you're in — so you're ready for that first patient, not just studied for it. Then $20/month, cancel anytime: https://www.patreon.com/checkout/pearlsandprep?rid=29362056 🎁 Join as a free member to access 50 Pearls from Pearls & Prep — 50 super high-yield pearls to sharpen your practice. 📚 Members get both books free — Board Bombs: PMHNP 250 Questions ($49.99) and the 100 Psychiatric Interview Tips E-Book ($39.99). Not a member yet? Both are in the shop: https://www.patreon.com/c/pearlsandprep/shop ⭐ Enjoying the show? Please rate and review Pearls and Prep on Apple Podcasts or Spotify — it really helps! 🌐 PearlsandPrep.com — scan this episode's Street Takes card, read the deep-dive articles, and unlock the full clinical library: https://pearlsandprep.com ✉️ Questions or a case you want covered? Write to NP Z: pearlsandpreppodcast@gmail.com Lamotrigine (Lamictal) may be the most misunderstood mood stabilizer on your shelf. Yes, it carries an FDA approval in Bipolar I — and no, it will not touch the manic patient pacing the ER at 3 a.m., and it will not rescue the bipolar depression sitting in front of you this week either. In this bonus episode NP Z busts the myths and gives you four pearls: what lamotrigine actually does (it is a floor, not a ceiling), how to survive the titration and the rash, the restart rule that punishes a forgotten refill, and the side-effect profile that makes it the low-drama maintenance drug patients actually stay on. 🧱 Pearl 1 — It's a floor, not a ceiling. Lamotrigine is FDA-approved for the maintenance treatment of Bipolar I disorder — to delay the time to the next mood episode in adults treated for an acute episode with standard therapy. Its strength is holding the floor: preventing the slide back into depression. It is not a treatment for acute mania, it is weak at preventing mania, and — because the titration takes weeks — it is not your rescue drug for an acute bipolar depression either. Mechanistically it stabilizes voltage-gated sodium channels on over-excited neurons, so those neurons release less glutamate, the brain's main excitatory neurotransmitter. The prescriber's question is always: which pole am I treating right now, and which pole am I preventing next? For the mania in front of you, reach for lithium, valproate, or an antimanic second-generation antipsychotic (combination therapy for severe mania), and review antidepressants or stimulants that may be driving it. For acute bipolar depression, the FDA-approved options include quetiapine and cariprazine. Lamotrigine gets added for the long game — with a mania plan standing behind it. 🐢 Pearl 2 — Start low, go slow, and respect the rash. The standard bipolar titration (no valproate, no enzyme inducers): 25 mg daily for two weeks, 50 mg daily for two weeks, 100 mg at week five, and the 200 mg target from week six — patience forced on us by the Stevens-Johnson risk. Roughly 1 in 10 patients develops a benign rash, and you usually cannot tell a benign rash from the first frame of a serious one — so the rule is to stop at the first sign of rash unless it is clearly not drug-related, knowing even stopping may not halt progression. Nearly all life-threatening rashes appear in weeks 2–8, but isolated cases have occurred after six months, so NP Z asks about rash at every visit, forever. Red flags that escalate care urgently: mouth, eye, or genital lesions; blistering or peeling; fever; malaise; sore throat; skin pain; facial swelling; swollen lymph nodes — with a CBC with differential and liver tests in the workup. Counsel patients not to start new soaps or lotions during titration, so a new rash has fewer impostors. And mind the interactions while you titrate: valproate blocks lamotrigine clearance and can more than double levels (halve the dose), while estrogen-containing contraceptives lower lamotrigine levels. 🔁 Pearl 3 — Missed doses can mean starting over. A patient who ran out a week ago cannot simply resume 200 mg. Per the FDA label, if lamotrigine has been discontinued for more than five half-lives, restart with the initial titration — all the way back to 25 mg. The exact math shifts with the half-life, and the half-life shifts with whatever else is on board (much longer with valproate, shorter with enzyme inducers), which is why a real medication reconciliation matters. Prevention beats the restart: educate patients that this is not a medication you can casually forget on vacation, because the price of a gap is six weeks of climbing back. ⚖️ Pearl 4 — The side-effect profile is the superpower. Past the titration, lamotrigine is famously low-drama: essentially weight-neutral, with only about 0.4% of patients gaining 7% or more of body weight in the acute bipolar depression trial data — against roughly 28–30% on olanzapine. No routine lab monitoring, no meaningful sedation signal over placebo for most patients, and no established sexual dysfunction burden. Set that beside lithium's thyroid, kidney, and calcium monitoring and valproate's weight and liver profile, and the adherence logic writes itself: the problems that drive patients off mood stabilizers are largely absent here. Weight gain is one of the best-documented drivers of non-adherence in bipolar pharmacotherapy — a mood stabilizer patients don't dread taking is a mood stabilizer that keeps working. 🔎 Accuracy notes: (1) On mic, NP Z cites a serious-rash figure of about 0.02% (1 in 5,000) attributed to CANMAT 2018. The FDA label reports serious rash in bipolar trials at 0.08% in adults receiving lamotrigine as initial monotherapy and 0.13% as adjunctive therapy — the label figures are the ones to carry into practice. (2) Norquetiapine is described in this episode with the same shorthand used before: precisely, it is an active metabolite that inhibits the norepinephrine transporter and has partial-agonist activity at 5-HT1A — it is not itself an SNRI. (3) The on-mic statement that weight gain drives "60%" of non-adherence could not be verified in the CANMAT/ISBD 2018 guideline text; the description above states the well-supported version — weight gain is a leading, well-documented driver of non-adherence. 📖 Sources & further reading: • U.S. Food and Drug Administration. Lamictal (lamotrigine) prescribing information. (Boxed warning: serious skin rashes — 0.08% initial monotherapy and 0.13% adjunctive therapy in bipolar trials; nearly all life-threatening cases within 2–8 weeks, isolated cases after prolonged treatment. Bipolar I maintenance indication; Table 5 escalation regimen 25→50→100→200 mg; restart with initial dosing after discontinuation of more than 5 half-lives; valproate interaction roughly doubling half-life; estrogen-containing contraceptives decreasing lamotrigine levels.) • Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20(2):97-170. (Lamotrigine's maintenance role and depression-pole strength; safety and tolerability tables, including rash and weight.) • Calabrese JR, Bowden CL, Sachs G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry. 2003;60(4):392-400. (Lamotrigine significantly delayed time to intervention for a mood episode — driven by depression prevention.) • U.S. Food and Drug Administration. Seroquel (quetiapine) and Vraylar (cariprazine) prescribing information. (Both agents carry FDA approval for depressive episodes associated with bipolar disorder — the acute-depression lane lamotrigine does not fill.) 🎧 Pearls & Prep — new episodes every Tuesday. Hosted by NP Z, Duke-trained Psychiatric Nurse Practitioner. ⚖️ Disclaimer: Pearls and Prep is an educational podcast and is not medical advice. All views expressed are exclusively those of NP Z and do not represent — and are not endorsed by — any other entity or organization. These perspectives are offered solely to build conceptual appreciation of psychiatric topics; they are not a substitute for clinical judgment, current clinical guidelines, or primary references. Always use appropriate resources and your own clinical judgment when making decisions about individual patients. Nothing in this episode creates a clinician–patient relationship. 🎓 NP Z's Most Recommended Resources — Pass Your Boards & See Your First Patient The exact shelf behind this podcast: the textbooks open on NP Z's desk, and his own BOARD BOMBS™ + Interview Tips. 👉 pearlsandprep.com/resources Your board date is already on the calendar, and your first patient is already on someone's schedule. Build the shelf they're both counting on — start today.

The Top Residual Symptoms That Predict Relapse — and How to Map an SSRI or SGA to Each One

💎 Try Boss Pearl FREE for 7 days — the full library: every deep dive, the Diagnosing curriculum, and both books free the moment you're in — so you're ready for that first patient, not just studied for it. Then $20/month, cancel anytime: https://www.patreon.com/checkout/pearlsandprep?rid=29362056 🎁 Join as a free member to access 50 Pearls from Pearls & Prep — 50 super high-yield pearls to sharpen your practice. 📚 Members get both books free — Board Bombs: PMHNP 250 Questions ($49.99) and the 100 Psychiatric Interview Tips E-Book ($39.99). Not a member yet? Both are in the shop: https://www.patreon.com/c/pearlsandprep/shop ⭐ Enjoying the show? Please rate and review Pearls and Prep on Apple Podcasts or Spotify — it really helps! 🌐 PearlsandPrep.com — scan this episode's Street Takes card, read the deep-dive articles, and unlock the full clinical library: https://pearlsandprep.com ✉️ Questions or a case you want covered? Write to NP Z: pearlsandpreppodcast@gmail.com Your patient "remitted." The suicidal thoughts are gone, the mood is up, they're back at pickleball — and all that remains is a little insomnia and a little fatigue. Harmless leftovers? In the classic follow-up data, that patient relapses at roughly three times the rate of the patient who remitted clean: 76% versus 25%. In this bonus episode NP Z makes the case that "almost better" is the most dangerous address in depression care — and gives you the checklist for telling a true residual symptom from the dozen impostors that imitate one, plus the symptom-by-symptom map for putting the last embers out. 🔥 Pearl 1 — The number that should change how you chart. Paykel's cohort followed patients to remission and beyond: those who carried residual symptoms relapsed at 76%, those who remitted clean at 25% — about three times the risk, and they relapsed faster. Layer on the STAR*D reality that only about a third of patients remit on the first antidepressant, and the clinical posture writes itself: response is a waypoint, remission is the job, and a symptom-free remission is the finish line. 😴 Pearl 2 — Sleep is the number-one leftover. Across cohorts, sleep disturbance is the most common and most persistent residual symptom — in the STAR*D remitter analysis, mid-nocturnal insomnia (the 3 a.m. wide-awake) led the list at roughly six in ten, ahead of sleep-onset and early-morning insomnia. Residual insomnia and residual anxiety are also the leftovers most consistently tied to relapse. So the rule: never pick an antidepressant without a sleep plan — CBT-I, a sleep-targeting agent (trazodone, low-dose doxepin, mirtazapine where its profile fits), or a deliberate reason you don't need one. 🧾 Pearl 3 — Know the whole leftover list, including the one that isn't in the DSM. Behind sleep come fatigue, anxiety, poor concentration, appetite and GI complaints, psychomotor change, lingering sad mood and anhedonia — and, strikingly, headaches and somatic aches, which aren't depressive criteria at all yet show up constantly among residual complaints (in Paykel's series, somatic symptoms appeared in nearly every patient with residual symptoms). The patient who "can't get going," can't focus enough to hold the job, and aches everywhere is not done, whatever the total score says. 🕵️ Pearl 4 — Before you treat a residual symptom, interrogate it. The episode's differential, in order: Is the diagnosis wrong — bipolar spectrum cycling under an antidepressant, an unrecognised personality disorder, untreated ADHD wearing a "brain fog" costume? Is the trial even adequate — six to twelve weeks at a real dose, or still parked at sertraline 25 mg? Are they actually taking it? Is this the drug, not the disease — SSRI apathy and emotional blunting, 5-HT2A-driven restlessness, REM disruption with vivid dreams? And the impostors nobody asks about: sleep apnea (snoring, morning headaches, the unused CPAP in the closet), hypothyroidism, anaemia, low B12 or folate, chronic pain, substances and their withdrawals, and the divorce happening in the background. Polypharmacy aimed at an impostor just muddies the water. 🎯 Pearl 5 — When it IS residual, match the drug to the ember. Anhedonia, apathy, dead motivation: an FDA-approved adjunct SGA — aripiprazole, brexpiprazole, or cariprazine, whose D3 preference is the mechanistic bet for the reward-circuit symptoms; their 5-HT2A antagonism releases serotonin's brake on dopamine in the circuits where that helps. Residual insomnia: quetiapine in its 150–300 mg adjunct range will put them to sleep — with an honest metabolic conversation — and its metabolite norquetiapine adds noradrenergic and 5-HT1A activity NP Z also leans on for residual anxiety. Fatigue and poor concentration: bupropion. Sexual dysfunction: bupropion again. The classic bench is still real: lithium, T3 (with endocrine or primary-care partnership), and off-label modafinil for fatigue, named as off-label with misuse potential and a Schedule IV caution. 🧠 Pearl 6 — Therapy is the relapse insurance. CBT and mindfulness-based cognitive therapy are not garnish; for the ruminating patient especially, therapy is what makes remission durable, and where trauma rides along it is often the main event. Medication puts out the fire; therapy fireproofs the house. 🔎 Accuracy note: norquetiapine is described in this episode in shorthand. Precisely: it is an active metabolite that inhibits the norepinephrine transporter and has partial-agonist activity at 5-HT1A — it is not itself an SNRI. Quetiapine's FDA-approved adjunctive range in major depression is 150–300 mg/day. 📖 Sources & further reading: • Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A. Residual symptoms after partial remission: an important outcome in depression. Psychol Med. 1995;25(6):1171-1180. (Relapse in 76% [13/17] of patients with residual symptoms vs 25% [10/40] without; somatic symptoms in 18 of 19 patients with residual symptoms.) • Nierenberg AA, Husain MM, Trivedi MH, et al. Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. Psychol Med. 2010;40(1):41-50. (Among remitters with residual symptoms, mid-nocturnal insomnia was the most frequent and persistent at 58.8%; residual symptoms predicted relapse.) • Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28-40. (First-step remission 28% by HAM-D, 33% by QIDS-SR.) • Judd LL, Akiskal HS, Maser JD, et al. Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord. 1998;50(2-3):97-108. • U.S. Food and Drug Administration. Seroquel XR (quetiapine) prescribing information. (Adjunctive treatment of major depressive disorder: 150–300 mg/day; norquetiapine pharmacology — norepinephrine transporter inhibition, 5-HT1A partial agonism.) • U.S. Food and Drug Administration. Vraylar (cariprazine) prescribing information. (D3-preferring dopamine D3/D2 partial agonist; adjunctive treatment of major depressive disorder.) • Lam RW, Kennedy SH, Mochrie R, et al; CANMAT Group. 2023 Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for major depressive disorder. (Adjunctive agents, lithium and triiodothyronine augmentation, and psychotherapy including CBT and MBCT for relapse prevention.) 🎧 Pearls & Prep — new episodes every Tuesday. Hosted by NP Z, Duke-trained Psychiatric Nurse Practitioner. ⚖️ Disclaimer: Pearls and Prep is an educational podcast and is not medical advice. All views expressed are exclusively those of NP Z and do not represent — and are not endorsed by — any other entity or organization. These perspectives are offered solely to build conceptual appreciation of psychiatric topics; they are not a substitute for clinical judgment, current clinical guidelines, or primary references. Always use appropriate resources and your own clinical judgment when making decisions about individual patients. Nothing in this episode creates a clinician–patient relationship. 🎓 NP Z's Most Recommended Resources — Pass Your Boards & See Your First Patient The exact shelf behind this podcast: the textbooks open on NP Z's desk, and his own BOARD BOMBS™ + Interview Tips. 👉 pearlsandprep.com/resources Your board date is already on the calendar, and your first patient is already on someone's schedule. Build the shelf they're both counting on — start today.

Prozac vs Paxil: My Verdict — and the Exact Patient I'd Give Each One

💎 Try Boss Pearl FREE for 7 days — the full library: every deep dive, the Diagnosing curriculum, and both books free the moment you're in — so you're ready for that first patient, not just studied for it. Then $20/month, cancel anytime: https://www.patreon.com/checkout/pearlsandprep?rid=29362056 🎁 Join as a free member to access 50 Pearls from Pearls & Prep — 50 super high-yield pearls to sharpen your practice. 📚 Members get both books free — Board Bombs: PMHNP 250 Questions ($49.99) and the 100 Psychiatric Interview Tips E-Book ($39.99). Not a member yet? Both are in the shop: https://www.patreon.com/c/pearlsandprep/shop ⭐ Enjoying the show? Please rate and review Pearls and Prep on Apple Podcasts or Spotify — it really helps! 🌐 PearlsandPrep.com — scan this episode's Street Takes card, read the deep-dive articles, and unlock the full clinical library: https://pearlsandprep.com ✉️ Questions or a case you want covered? Write to NP Z: pearlsandpreppodcast@gmail.com School teaches you that all SSRIs are more or less equal for depression — and on efficacy, that's roughly true. It will not get you to the finish line. In this bonus episode, NP Z puts the two most opposite SSRIs in the class head to head: Prozac, the activating marathon runner with a half-life measured in days, and Paxil, the sedating sprinter gone from the body in about a day. Same class, same dragon — radically different patients. This is the prescriber's verdict on which one earns which chair, and why "equally efficacious" never means "prescribe them equally." ⚡ Pearl 1 — Prozac is the activator, and that's a receptor story. Fluoxetine's 5-HT2C antagonism disinhibits frontal dopamine and norepinephrine release, which is why it so often lifts the flat, slowed, oversleeping, overeating depression that can't get out of bed. That profile is why NP Z reaches for it over bupropion when anxiety rides along — the energizing SSRI that still treats the anxiety. It also carries an FDA approval for bulimia nervosa at 60 mg/day, and pediatric approvals Paxil doesn't have (depression ages 8–18, OCD ages 7–17). Versatility is the brand. ⏳ Pearl 2 — Half-life is destiny. Fluoxetine's half-life is 4–6 days, and its active metabolite norfluoxetine runs longer still — miss a dose, miss three, and the drug forgives you; it is the SSRI that protects imperfect adherers from discontinuation symptoms. Paroxetine's half-life is about 21 hours: one pharmacy hiccup can put a patient in withdrawal. The paradox you'll see in clinic — Paxil patients are often your most religiously adherent, because they know exactly what missing feels like. 🌙 Pearl 3 — Paxil is the sedating outlier of the class. It is the most potent serotonin reuptake blocker of the SSRIs and the most anticholinergic — structurally the closest thing the class has to a tricyclic: sleepiness, dry mouth, constipation, sweating, and the heaviest sexual dysfunction of any SSRI, an effect strong enough that the literature has used it deliberately for paraphilic disorders. For the very anxious, agitated patient whose chief demand is "fix my sleep," that sedation is a feature — one drug doing two jobs, instead of starting something activating and then adding a second agent for the insomnia it stirred up. 🗂️ Pearl 4 — Count the FDA indications and Paxil wins on breadth: major depression, OCD, panic disorder, social anxiety disorder, GAD, PTSD, PMDD, and — in a low-dose formulation — menopausal hot flashes. Fluoxetine is effective in anxiety and PTSD but was never FDA-approved for GAD or PTSD; the trials simply weren't run for those labels. Prozac answers with its own unique territory: the olanzapine–fluoxetine combination (Symbyax) is FDA-approved for bipolar I depression and treatment-resistant depression. If NP Z could stock only one antidepressant on a desert island, it would be Prozac — children and adults, an eating-disorder approval, and a bipolar-depression door no other SSRI opens alone. 🧪 Pearl 5 — Both are strong CYP2D6 inhibitors, so both can raise levels of tricyclics, metoprolol, and antipsychotics — mind the akathisia when levels climb. The difference is duration: stop Paxil and the inhibition fades in days; stop Prozac and norfluoxetine keeps inhibiting 2D6 for weeks after the last dose. The drug that forgives missed doses also lingers in every interaction — plan switches and washouts around it. 🚫 Pearl 6 — Know who never gets Paxil. Pregnancy: paroxetine carries a first-trimester cardiac malformation signal that makes it the SSRI to steer around in anyone who could conceive. The elderly: its anticholinergic load — confusion, constipation, urinary retention, falls — makes it a no-go in older adults. And the poorly adherent, per Pearl 2. Both drugs carry the class boxed warning for suicidality under age 25. The verdict, in one breath: the low-energy, forgetful teenager with a past withdrawal or an eating-disorder thread gets Prozac; the reliably adherent, non-pregnant, not-elderly adult who is anxious to the bone and cannot sleep may get Paxil — and will thank you for it. 📖 Sources & further reading: • U.S. Food and Drug Administration. Prozac (fluoxetine) prescribing information. (Half-life of fluoxetine and norfluoxetine, CYP2D6 inhibition, and the approved indications including bulimia nervosa and pediatric depression and OCD.) • U.S. Food and Drug Administration. Paxil (paroxetine) prescribing information. (Approximately 21-hour half-life, discontinuation syndrome, anticholinergic effects, and the pregnancy warning regarding first-trimester cardiovascular malformations.) • Cipriani A, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391(10128):1357-1366. (Antidepressants broadly comparable in efficacy — tolerability and pharmacology drive the real-world choice.) • Stahl SM. Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 5th ed. Cambridge University Press; 2021. (Fluoxetine's 5-HT2C-mediated activating profile; paroxetine's SERT potency, anticholinergic and sedating properties.) 🎧 Pearls & Prep — new episodes every Tuesday. Hosted by NP Z, Duke-trained Psychiatric Nurse Practitioner. ⚖️ Disclaimer: Pearls and Prep is an educational podcast and is not medical advice. All views expressed are exclusively those of NP Z and do not represent — and are not endorsed by — any other entity or organization. These perspectives are offered solely to build conceptual appreciation of psychiatric topics; they are not a substitute for clinical judgment, current clinical guidelines, or primary references. Always use appropriate resources and your own clinical judgment when making decisions about individual patients. Nothing in this episode creates a clinician–patient relationship. 🎓 NP Z's Most Recommended Resources — Pass Your Boards & See Your First Patient The exact shelf behind this podcast: the textbooks open on NP Z's desk, and his own BOARD BOMBS™ + Interview Tips. 👉 pearlsandprep.com/resources Your board date is already on the calendar, and your first patient is already on someone's schedule. Build the shelf they're both counting on — start today.

Trazodone vs Remeron for Sleep: My Verdict — and the Exact Patient I'd Give Each One

💎 Try Boss Pearl FREE for 7 days — the full library: every deep dive, the Diagnosing curriculum, and both books free the moment you're in — so you're ready for that first patient, not just studied for it. Then $20/month, cancel anytime: https://www.patreon.com/checkout/pearlsandprep?rid=29362056 🎁 Join as a free member to access 50 Pearls from Pearls & Prep — 50 super high-yield pearls to sharpen your practice. 📚 Members get both books free — Board Bombs: PMHNP 250 Questions ($49.99) and the 100 Psychiatric Interview Tips E-Book ($39.99). Not a member yet? Both are in the shop: https://www.patreon.com/c/pearlsandprep/shop ⭐ Enjoying the show? Please rate and review Pearls and Prep on Apple Podcasts or Spotify — it really helps! 🌐 PearlsandPrep.com — scan this episode's Street Takes card, read the deep-dive articles, and unlock the full clinical library: https://pearlsandprep.com ✉️ Questions or a case you want covered? Write to NP Z: pearlsandpreppodcast@gmail.com "I heard about trazodone and Remeron for sleep. Which one should I take — and why?" Sooner or later a patient asks you exactly that, and "they're both sedating antidepressants" is not an answer. In this bonus episode, NP Z gives his prescriber's verdict: why he reaches for Remeron first, the exact patient trazodone beats it for, and the dose paradoxes that make these two drugs behave like different medications at different doses. CBT-I stays the gold standard for chronic insomnia — this is the honest street guide to the two pills everyone reaches for when sleep, mood, and anxiety all arrive in the same patient. 🛏️ Pearl 1 — They're not two sleep meds. Remeron (mirtazapine) is a full antidepressant that also sleeps you — FDA-approved for major depression, working on mood and anxiety around the clock. Trazodone at the 50–100 mg doses everyone actually prescribes is a sleep tool wearing an antidepressant's label: it IS FDA-approved for depression, but at far higher doses that sedation rarely lets patients reach. Know which job you're hiring each drug to do. 🎯 Pearl 2 — The Remeron patient. Depressed, anxious, up all night ruminating — and losing weight because they can't eat. Remeron treats the whole picture at once, and it works on sleep from day one, which buys you rapport no taper schedule can. It's also the escape hatch from SSRI sexual side effects and a GI-friendly option (5-HT3 blockade) for the patient whose anxiety lives in their stomach. Screen hard for the deal-breaker: weight gain. And have the honest conversation — is regaining weight that depression stole a side effect, or is it recovery? ⚖️ Pearl 3 — The trazodone patient. Needs sleep, refuses weight gain — full stop. Classic case: insomnia that arrived WITH the SSRI or SNRI, where a low-dose add-on steadies the night while the primary antidepressant settles in. Say it out loud in the visit: trazodone for insomnia is off-label. Patients deserve to know which of their prescriptions are proven for what they're taking them for. 🔄 Pearl 4 — Both drugs change personalities with dose. Mirtazapine is often MORE sedating at 15 mg than at 30–45 mg: as the dose climbs, noradrenergic effects rise and the fog can paradoxically lift — patients report more energy, not less. Trazodone runs the opposite trap: its antidepressant range sits behind a sedation ceiling most patients never push through. Dose is not a detail with these two; dose is the drug. 🌙 Pearl 5 — Protect the architecture. Both agents block 5-HT2A, which deepens slow-wave sleep without the REM suppression SSRIs and SNRIs can cause. That matters most in trauma: REM sleep is where emotional memory processing happens, and a medication plan that crushes it is working against the patient's recovery. When a trauma patient can't sleep, reach for the agents that guard the cycle, not the ones that flatten it. ⚠️ Pearl 6 — The safety screens are different, so ask different questions. Remeron: weight and sedation screen patients out fast — ask about both at every visit. Trazodone: orthostatic hypotension and falls, especially in older patients; a small QTc signal; and priapism — rare, but a true emergency every male patient should hear about once, in plain language. Both drugs carry the class boxed warning for suicidality under age 25, and both deserve bipolar-switch caution before you start. 📖 Sources & further reading: • American College of Physicians. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians (Qaseem A, et al.). Ann Intern Med. 2016;165(2):125-133. (Cognitive behavioral therapy for insomnia as the first-line treatment for chronic insomnia disorder.) • U.S. Food and Drug Administration. Remeron (mirtazapine) prescribing information. (Alpha-2 antagonism, 5-HT2/5-HT3 antagonism, histamine H1 sedation, weight gain, and the antidepressant indication.) • U.S. Food and Drug Administration. Trazodone hydrochloride prescribing information. (Depression indication and dosing range; warnings for orthostatic hypotension, QT prolongation, and priapism.) • Stahl SM. Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 5th ed. Cambridge University Press; 2021. (Mirtazapine's dose-dependent noradrenergic effects; trazodone's dose-dependent receptor profile.) 🎧 Pearls & Prep — new episodes every Tuesday. Hosted by NP Z, Duke-trained Psychiatric Nurse Practitioner. ⚖️ Disclaimer: Pearls and Prep is an educational podcast and is not medical advice. All views expressed are exclusively those of NP Z and do not represent — and are not endorsed by — any other entity or organization. These perspectives are offered solely to build conceptual appreciation of psychiatric topics; they are not a substitute for clinical judgment, current clinical guidelines, or primary references. Always use appropriate resources and your own clinical judgment when making decisions about individual patients. Nothing in this episode creates a clinician–patient relationship. 🎓 NP Z's Most Recommended Resources — Pass Your Boards & See Your First Patient The exact shelf behind this podcast: the textbooks open on NP Z's desk, and his own BOARD BOMBS™ + Interview Tips. 👉 pearlsandprep.com/resources Your board date is already on the calendar, and your first patient is already on someone's schedule. Build the shelf they're both counting on — start today.

ADHD vs Bipolar Disorder: 6 Pearls That Separate Traits from States — Plus Why Mood Gets Treated First

💎 Try Boss Pearl FREE for 7 days — the full library: every deep dive, the Diagnosing curriculum, and both books free the moment you're in — so you're ready for that first patient, not just studied for it. Then $20/month, cancel anytime: https://www.patreon.com/checkout/pearlsandprep?rid=29362056 🎁 Join as a free member to access 50 Pearls from Pearls & Prep — 50 super high-yield pearls to sharpen your practice. 📚 Members get both books free — Board Bombs: PMHNP 250 Questions ($49.99) and the 100 Psychiatric Interview Tips E-Book ($39.99). Not a member yet? Both are in the shop: https://www.patreon.com/c/pearlsandprep/shop ⭐ Enjoying the show? Please rate and review Pearls and Prep on Apple Podcasts or Spotify — it really helps! 🌐 PearlsandPrep.com — scan this episode's Street Takes card, read the deep-dive articles, and unlock the full clinical library: https://pearlsandprep.com ✉️ Questions or a case you want covered? Write to NP Z: pearlsandpreppodcast@gmail.com Restless, talking fast, can't focus, barely sleeping — in a 45-minute eval, is that ADHD, or the front edge of mania? The overlap is real, the treatments pull in opposite directions, and getting it backwards has consequences. In this bonus episode, NP Z lays out six pearls that separate ADHD from bipolar disorder cleanly: one master question (trait or state?), the sleep clue that settles arguments, how to read distractibility and impulsivity by their timelines, the DSM-5 duration rules that anchor both diagnoses, and why mood always gets treated first. 🧭 Pearl 1 — Trait vs state: the master question. ADHD is the patient's baseline — "I've always been this way," threaded back through childhood, report cards, and IEPs. Bipolar is a marked departure from baseline: the reserved patient who suddenly talks nonstop for a month, sleeps a few hours, and spends thousands is describing a state, not a personality. The bipolar patient often disowns the episode ("I'm not someone who buys $9,000 worth of makeup at 3 AM"); the ADHD patient owns their pattern completely. When you're stuck, ask: is this a trait, or is this a state? 😴 Pearl 2 — Sleep is your best clue. The patient with ADHD usually WANTS to sleep — they get distracted away from it (the phone, nine open tabs, one more video), they feel tired the next day, and their mood is unchanged. Mania is the opposite physiology: a decreased NEED for sleep. A few hours, no fatigue, energy to spare, and grandiose plans at 3 AM. Wanting sleep and failing to get it is ADHD's story; not needing sleep at all is bipolar's. 🎯 Pearl 3 — Distractibility is in both; read its company. Distractibility alone separates nothing — both patients lose the thread. In ADHD it is lifelong, all-day, and drifts toward ordinary, benign things; the patient zones out or checks their phone. In mania the distractibility rides with elevated or irritable mood, racing thoughts, and ideas that are grandiose, poorly linked, and out of character. When distractibility confuses you, loop in the rest of the picture: mood, sleep, hypersexuality, grandiosity. ⚡ Pearl 4 — Impulsivity: check the timeline and the scale. ADHD impulsivity is chronic and small — interrupting, not waiting a turn, spending a bit too much, leaping before looking, for as long as anyone can remember. Bipolar impulsivity is sudden and large: spending sprees, abrupt hypersexuality, decisions that alarm the patient themselves once the episode passes. That aftermath is diagnostic gold — bipolar impulsivity is usually ego-dystonic, remembered with regret ("that's not me"); ADHD impulsivity is just Tuesday. 📏 Pearl 5 — Know the DSM-5 clock rules cold. ADHD: several symptoms present before age 12, a pattern lasting at least six months, five or more symptoms for patients 17 and older, showing up in two or more settings. Mania: at least one week of abnormally elevated, expansive, or irritable mood AND increased energy or activity, present most of the day, nearly every day. One diagnosis is written across years; the other is measured in a single unmistakable week. 💊 Pearl 6 — Treat mood first. This is where the differential stops being academic. When bipolar disorder is in the room, stabilize mood before treating ADHD — an ADHD agent started on its own in an unstabilized bipolar patient carries a real risk of precipitating mania and making the bipolar illness harder to treat from there. The mood stabilizer is the safety net; whatever ADHD symptoms remain once mood is controlled get addressed next, stimulant or non-stimulant. And expect this collision often: the two are heavily comorbid in both directions — roughly 1 in 13 adults with ADHD also have bipolar disorder, and roughly 1 in 6 adults with bipolar disorder also have ADHD. 📖 Sources & further reading: • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). American Psychiatric Association Publishing; 2022. (ADHD onset-before-12, duration, and symptom-count criteria; the one-week duration criterion for a manic episode.) • Katzman MA, Bilkey TS, Chokka PR, Fallu A, Klassen LJ. Adult ADHD and comorbid disorders: clinical implications of a dimensional approach. BMC Psychiatry. 2017;17:302. (Comorbidity between adult ADHD and bipolar disorder, overlapping symptoms, and treating the most impairing condition first.) • Stahl SM. Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 5th ed. Cambridge University Press; 2021. 🎧 Pearls & Prep — new episodes every Tuesday. Hosted by NP Z, Duke-trained Psychiatric Nurse Practitioner. ⚖️ Disclaimer: Pearls and Prep is an educational podcast and is not medical advice. All views expressed are exclusively those of NP Z and do not represent — and are not endorsed by — any other entity or organization. These perspectives are offered solely to build conceptual appreciation of psychiatric topics; they are not a substitute for clinical judgment, current clinical guidelines, or primary references. Always use appropriate resources and your own clinical judgment when making decisions about individual patients. Nothing in this episode creates a clinician–patient relationship. 🎓 NP Z's Most Recommended Resources — Pass Your Boards & See Your First Patient The exact shelf behind this podcast: the textbooks open on NP Z's desk, and his own BOARD BOMBS™ + Interview Tips. 👉 pearlsandprep.com/resources Your board date is already on the calendar, and your first patient is already on someone's schedule. Build the shelf they're both counting on — start today.

Bipolar I vs II Made Easy: Psychosis, Hospitalization & the Rules Students Mix Up

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.” Patients know the difference. Know the WHY! Join our clinical library today on PATREON! 👉 https://www.patreon.com/PearlsandPrep Bipolar I vs Bipolar II can get confusing fast. Does psychosis automatically mean Bipolar I? Can someone with Bipolar II experience psychosis? Does psychiatric hospitalization automatically qualify as mania? And do you really need seven days of symptoms to diagnose a manic episode? In this episode of Pearls and Prep, NPZ breaks down mania vs hypomania and the key diagnostic distinctions between Bipolar I and Bipolar II. We cover how hospitalization affects the duration requirement for mania, why a major depressive episode is not required for Bipolar I, how psychosis during an elevated mood episode changes the diagnosis, and why psychosis during a depressive episode is a different story. If you’re a psychiatric nurse practitioner student, PMHNP, psychiatry student, or mental health clinician trying to finally understand Bipolar I vs Bipolar II, mania, hypomania, psychotic features, and DSM-5-TR diagnostic criteria, this episode makes the distinctions easy to remember. 37 Bipolar I vs II Made Easy: Psychosis, Hospitalization & the Rules Students Mix Up Pearls and Prep pearlsandprep@mail.com https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

• Transcript

Strattera (Atomoxetine) vs Wellbutrin (Bupropion): Non-Stimulant Uses | PMHNP Boards

💎 Try Boss Pearl FREE for 7 days — the full library: every deep dive, the Diagnosing curriculum, and both books free the moment you're in — so you're ready for that first patient, not just studied for it. Then $20/month, cancel anytime: https://www.patreon.com/checkout/pearlsandprep?rid=29362056 🎁 Join as a free member to access 50 Pearls from Pearls & Prep — 50 super high-yield pearls to sharpen your practice. 📚 Members get both books free — Board Bombs: PMHNP 250 Questions ($49.99) and the 100 Psychiatric Interview Tips E-Book ($39.99). Not a member yet? Both are in the shop: https://www.patreon.com/c/pearlsandprep/shop ⭐ Enjoying the show? Please rate and review Pearls and Prep on Apple Podcasts or Spotify — it really helps! 🌐 PearlsandPrep.com — scan this episode's Street Takes card, read the deep-dive articles, and unlock the full clinical library: https://pearlsandprep.com ✉️ Questions or a case you want covered? Write to NP Z: pearlsandpreppodcast@gmail.com Atomoxetine (Strattera) and bupropion (Wellbutrin) both influence norepinephrine, ease attention difficulties, and carry no controlled-substance burden — yet they serve very different clinical purposes. This episode uses real-world psychopharmacology reasoning to compare them, so you grasp the why behind each choice rather than memorizing a list. Focused PMHNP boards prep that builds the clinical confidence to select the right non-stimulant option for the right patient. 🎧 Pearls & Prep — new episodes every Tuesday. Hosted by NP Z, Duke-trained Psychiatric Nurse Practitioner. ⚖️ Disclaimer: Pearls and Prep is an educational podcast and is not medical advice. All views expressed are exclusively those of NP Z and do not represent — and are not endorsed by — any other entity or organization. These perspectives are offered solely to build conceptual appreciation of psychiatric topics; they are not a substitute for clinical judgment, current clinical guidelines, or primary references. Always use appropriate resources and your own clinical judgment when making decisions about individual patients. Nothing in this episode creates a clinician–patient relationship. 🎓 NP Z's Most Recommended Resources — Pass Your Boards & See Your First Patient The exact shelf behind this podcast: the textbooks open on NP Z's desk, and his own BOARD BOMBS™ + Interview Tips. 👉 pearlsandprep.com/resources Your board date is already on the calendar, and your first patient is already on someone's schedule. Build the shelf they're both counting on — start today.

• Transcript
• Chapters

Saphris (Asenapine): Bipolar Mania & Schizophrenia Prescribing | PMHNP Boards

💎 Try Boss Pearl FREE for 7 days — the full library: every deep dive, the Diagnosing curriculum, and both books free the moment you're in — so you're ready for that first patient, not just studied for it. Then $20/month, cancel anytime: https://www.patreon.com/checkout/pearlsandprep?rid=29362056 🎁 Join as a free member to access 50 Pearls from Pearls & Prep — 50 super high-yield pearls to sharpen your practice. 📚 Members get both books free — Board Bombs: PMHNP 250 Questions ($49.99) and the 100 Psychiatric Interview Tips E-Book ($39.99). Not a member yet? Both are in the shop: https://www.patreon.com/c/pearlsandprep/shop ⭐ Enjoying the show? Please rate and review Pearls and Prep on Apple Podcasts or Spotify — it really helps! 🌐 PearlsandPrep.com — scan this episode's Street Takes card, read the deep-dive articles, and unlock the full clinical library: https://pearlsandprep.com ✉️ Questions or a case you want covered? Write to NP Z: pearlsandpreppodcast@gmail.com Asenapine (Saphris) remains one of the most overlooked second-generation antipsychotics in psychopharmacology. This episode maps exactly where it fits — bipolar I disorder, acute mania, mixed episodes, and schizophrenia — and explains why Saphris is dosed sublingually and what makes its receptor profile distinctive. You will leave understanding the why behind this SGA's niche, with sharper clinical confidence for PMHNP boards and real-world prescribing. 🎧 Pearls & Prep — new episodes every Tuesday. Hosted by NP Z, Duke-trained Psychiatric Nurse Practitioner. ⚖️ Disclaimer: Pearls and Prep is an educational podcast and is not medical advice. All views expressed are exclusively those of NP Z and do not represent — and are not endorsed by — any other entity or organization. These perspectives are offered solely to build conceptual appreciation of psychiatric topics; they are not a substitute for clinical judgment, current clinical guidelines, or primary references. Always use appropriate resources and your own clinical judgment when making decisions about individual patients. Nothing in this episode creates a clinician–patient relationship. 🎓 NP Z's Most Recommended Resources — Pass Your Boards & See Your First Patient The exact shelf behind this podcast: the textbooks open on NP Z's desk, and his own BOARD BOMBS™ + Interview Tips. 👉 pearlsandprep.com/resources Your board date is already on the calendar, and your first patient is already on someone's schedule. Build the shelf they're both counting on — start today.

• Transcript
• Chapters

Wellbutrin (Bupropion) vs Trintellix (Vortioxetine) After SSRI Failure | PMHNP Boards

💎 Try Boss Pearl FREE for 7 days — the full library: every deep dive, the Diagnosing curriculum, and both books free the moment you're in — so you're ready for that first patient, not just studied for it. Then $20/month, cancel anytime: https://www.patreon.com/checkout/pearlsandprep?rid=29362056 🎁 Join as a free member to access 50 Pearls from Pearls & Prep — 50 super high-yield pearls to sharpen your practice. 📚 Members get both books free — Board Bombs: PMHNP 250 Questions ($49.99) and the 100 Psychiatric Interview Tips E-Book ($39.99). Not a member yet? Both are in the shop: https://www.patreon.com/c/pearlsandprep/shop ⭐ Enjoying the show? Please rate and review Pearls and Prep on Apple Podcasts or Spotify — it really helps! 🌐 PearlsandPrep.com — scan this episode's Street Takes card, read the deep-dive articles, and unlock the full clinical library: https://pearlsandprep.com ✉️ Questions or a case you want covered? Write to NP Z: pearlsandpreppodcast@gmail.com When depression lifts on an SSRI but joy, motivation, and emotional range stay flat, is it residual depression or SSRI-induced emotional blunting? This episode compares bupropion (Wellbutrin) and vortioxetine (Trintellix) for exactly that stuck moment in practice. You will learn the psychopharmacology reasoning that separates the two, sharpening your differential diagnosis skills and building clinical confidence for PMHNP boards — so you understand the why before you switch. 🎧 Pearls & Prep — new episodes every Tuesday. Hosted by NP Z, Duke-trained Psychiatric Nurse Practitioner. ⚖️ Disclaimer: Pearls and Prep is an educational podcast and is not medical advice. All views expressed are exclusively those of NP Z and do not represent — and are not endorsed by — any other entity or organization. These perspectives are offered solely to build conceptual appreciation of psychiatric topics; they are not a substitute for clinical judgment, current clinical guidelines, or primary references. Always use appropriate resources and your own clinical judgment when making decisions about individual patients. Nothing in this episode creates a clinician–patient relationship. 🎓 NP Z's Most Recommended Resources — Pass Your Boards & See Your First Patient The exact shelf behind this podcast: the textbooks open on NP Z's desk, and his own BOARD BOMBS™ + Interview Tips. 👉 pearlsandprep.com/resources Your board date is already on the calendar, and your first patient is already on someone's schedule. Build the shelf they're both counting on — start today.

• Transcript
• Chapters

Vraylar (Cariprazine) vs Abilify (Aripiprazole): D2, D3 Differences | PMHNP Boards

💎 Try Boss Pearl FREE for 7 days — the full library: every deep dive, the Diagnosing curriculum, and both books free the moment you're in — so you're ready for that first patient, not just studied for it. Then $20/month, cancel anytime: https://www.patreon.com/checkout/pearlsandprep?rid=29362056 🎁 Join as a free member to access 50 Pearls from Pearls & Prep — 50 super high-yield pearls to sharpen your practice. 📚 Members get both books free — Board Bombs: PMHNP 250 Questions ($49.99) and the 100 Psychiatric Interview Tips E-Book ($39.99). Not a member yet? Both are in the shop: https://www.patreon.com/c/pearlsandprep/shop ⭐ Enjoying the show? Please rate and review Pearls and Prep on Apple Podcasts or Spotify — it really helps! 🌐 PearlsandPrep.com — scan this episode's Street Takes card, read the deep-dive articles, and unlock the full clinical library: https://pearlsandprep.com ✉️ Questions or a case you want covered? Write to NP Z: pearlsandpreppodcast@gmail.com Cariprazine (Vraylar) versus aripiprazole (Abilify): a practical, memorable comparison of two second-generation antipsychotics built around their D2 and D3 receptor differences. This episode covers the FDA indications for each SGA and the clinical reasoning behind choosing one over the other — the why that textbooks skip. Ideal PMHNP boards prep in psychopharmacology, giving new prescribers the clinical confidence to match the right antipsychotic to the right patient. 🎧 Pearls & Prep — new episodes every Tuesday. Hosted by NP Z, Duke-trained Psychiatric Nurse Practitioner. ⚖️ Disclaimer: Pearls and Prep is an educational podcast and is not medical advice. All views expressed are exclusively those of NP Z and do not represent — and are not endorsed by — any other entity or organization. These perspectives are offered solely to build conceptual appreciation of psychiatric topics; they are not a substitute for clinical judgment, current clinical guidelines, or primary references. Always use appropriate resources and your own clinical judgment when making decisions about individual patients. Nothing in this episode creates a clinician–patient relationship. 🎓 NP Z's Most Recommended Resources — Pass Your Boards & See Your First Patient The exact shelf behind this podcast: the textbooks open on NP Z's desk, and his own BOARD BOMBS™ + Interview Tips. 👉 pearlsandprep.com/resources Your board date is already on the calendar, and your first patient is already on someone's schedule. Build the shelf they're both counting on — start today.

• Transcript
• Chapters

Panic Disorder vs PTSD: Differential Diagnosis Case Study | PMHNP Boards

💎 Try Boss Pearl FREE for 7 days — the full library: every deep dive, the Diagnosing curriculum, and both books free the moment you're in — so you're ready for that first patient, not just studied for it. Then $20/month, cancel anytime: https://www.patreon.com/checkout/pearlsandprep?rid=29362056 🎁 Join as a free member to access 50 Pearls from Pearls & Prep — 50 super high-yield pearls to sharpen your practice. 📚 Members get both books free — Board Bombs: PMHNP 250 Questions ($49.99) and the 100 Psychiatric Interview Tips E-Book ($39.99). Not a member yet? Both are in the shop: https://www.patreon.com/c/pearlsandprep/shop ⭐ Enjoying the show? Please rate and review Pearls and Prep on Apple Podcasts or Spotify — it really helps! 🌐 PearlsandPrep.com — scan this episode's Street Takes card, read the deep-dive articles, and unlock the full clinical library: https://pearlsandprep.com ✉️ Questions or a case you want covered? Write to NP Z: pearlsandpreppodcast@gmail.com A patient has panic attacks, avoids driving, and recently witnessed a traumatic accident — PTSD seems obvious, but is it? This DSM-5-TR case study dissects panic disorder versus PTSD, teaching you to distinguish trauma-related avoidance from fear of another panic attack. You will work through the differential diagnosis the way experienced clinicians do, understanding the why behind each criterion. Essential PMHNP boards prep that builds genuine clinical confidence for one of psychiatry's trickiest distinctions. 🎧 Pearls & Prep — new episodes every Tuesday. Hosted by NP Z, Duke-trained Psychiatric Nurse Practitioner. ⚖️ Disclaimer: Pearls and Prep is an educational podcast and is not medical advice. All views expressed are exclusively those of NP Z and do not represent — and are not endorsed by — any other entity or organization. These perspectives are offered solely to build conceptual appreciation of psychiatric topics; they are not a substitute for clinical judgment, current clinical guidelines, or primary references. Always use appropriate resources and your own clinical judgment when making decisions about individual patients. Nothing in this episode creates a clinician–patient relationship. 🎓 NP Z's Most Recommended Resources — Pass Your Boards & See Your First Patient The exact shelf behind this podcast: the textbooks open on NP Z's desk, and his own BOARD BOMBS™ + Interview Tips. 👉 pearlsandprep.com/resources Your board date is already on the calendar, and your first patient is already on someone's schedule. Build the shelf they're both counting on — start today.

• Transcript
• Chapters

Schizoid vs Schizotypal Personality Disorder: Clinical Clues | PMHNP Boards

💎 Try Boss Pearl FREE for 7 days — the full library: every deep dive, the Diagnosing curriculum, and both books free the moment you're in — so you're ready for that first patient, not just studied for it. Then $20/month, cancel anytime: https://www.patreon.com/checkout/pearlsandprep?rid=29362056 🎁 Join as a free member to access 50 Pearls from Pearls & Prep — 50 super high-yield pearls to sharpen your practice. 📚 Members get both books free — Board Bombs: PMHNP 250 Questions ($49.99) and the 100 Psychiatric Interview Tips E-Book ($39.99). Not a member yet? Both are in the shop: https://www.patreon.com/c/pearlsandprep/shop ⭐ Enjoying the show? Please rate and review Pearls and Prep on Apple Podcasts or Spotify — it really helps! 🌐 PearlsandPrep.com — scan this episode's Street Takes card, read the deep-dive articles, and unlock the full clinical library: https://pearlsandprep.com ✉️ Questions or a case you want covered? Write to NP Z: pearlsandpreppodcast@gmail.com Schizoid and schizotypal personality disorders can look identical — isolated, detached, eccentric patients — but the reason they withdraw is completely different. Using practical outpatient examples, this episode breaks down the DSM-5-TR distinction through real clinical reasoning, so you grasp the why behind each diagnosis rather than memorizing criteria. A high-yield differential diagnosis lesson for PMHNP boards that builds the clinical confidence to tell these two apart in practice. 🎧 Pearls & Prep — new episodes every Tuesday. Hosted by NP Z, Duke-trained Psychiatric Nurse Practitioner. ⚖️ Disclaimer: Pearls and Prep is an educational podcast and is not medical advice. All views expressed are exclusively those of NP Z and do not represent — and are not endorsed by — any other entity or organization. These perspectives are offered solely to build conceptual appreciation of psychiatric topics; they are not a substitute for clinical judgment, current clinical guidelines, or primary references. Always use appropriate resources and your own clinical judgment when making decisions about individual patients. Nothing in this episode creates a clinician–patient relationship. 🎓 NP Z's Most Recommended Resources — Pass Your Boards & See Your First Patient The exact shelf behind this podcast: the textbooks open on NP Z's desk, and his own BOARD BOMBS™ + Interview Tips. 👉 pearlsandprep.com/resources Your board date is already on the calendar, and your first patient is already on someone's schedule. Build the shelf they're both counting on — start today.

• Transcript
• Chapters

Latuda (Lurasidone): When It Shines & When It Falls Short | PMHNP Boards

💎 Try Boss Pearl FREE for 7 days — the full library: every deep dive, the Diagnosing curriculum, and both books free the moment you're in — so you're ready for that first patient, not just studied for it. Then $20/month, cancel anytime: https://www.patreon.com/checkout/pearlsandprep?rid=29362056 🎁 Join as a free member to access 50 Pearls from Pearls & Prep — 50 super high-yield pearls to sharpen your practice. 📚 Members get both books free — Board Bombs: PMHNP 250 Questions ($49.99) and the 100 Psychiatric Interview Tips E-Book ($39.99). Not a member yet? Both are in the shop: https://www.patreon.com/c/pearlsandprep/shop ⭐ Enjoying the show? Please rate and review Pearls and Prep on Apple Podcasts or Spotify — it really helps! 🌐 PearlsandPrep.com — scan this episode's Street Takes card, read the deep-dive articles, and unlock the full clinical library: https://pearlsandprep.com ✉️ Questions or a case you want covered? Write to NP Z: pearlsandpreppodcast@gmail.com Lurasidone (Latuda) is among the most distinctive — and most misunderstood — second-generation antipsychotics in psychopharmacology. This episode breaks down exactly when Latuda shines, where it falls short, and how experienced clinicians reason through prescribing it in real practice. You will move beyond surface-level facts to the why behind each decision, building clinical confidence with this SGA. Focused PMHNP boards prep that turns a confusing medication into a clear, prescribable option. 🎧 Pearls & Prep — new episodes every Tuesday. Hosted by NP Z, Duke-trained Psychiatric Nurse Practitioner. ⚖️ Disclaimer: Pearls and Prep is an educational podcast and is not medical advice. All views expressed are exclusively those of NP Z and do not represent — and are not endorsed by — any other entity or organization. These perspectives are offered solely to build conceptual appreciation of psychiatric topics; they are not a substitute for clinical judgment, current clinical guidelines, or primary references. Always use appropriate resources and your own clinical judgment when making decisions about individual patients. Nothing in this episode creates a clinician–patient relationship. 🎓 NP Z's Most Recommended Resources — Pass Your Boards & See Your First Patient The exact shelf behind this podcast: the textbooks open on NP Z's desk, and his own BOARD BOMBS™ + Interview Tips. 👉 pearlsandprep.com/resources Your board date is already on the calendar, and your first patient is already on someone's schedule. Build the shelf they're both counting on — start today.

• Transcript
• Chapters

Effexor (Venlafaxine) vs Cymbalta (Duloxetine): SNRI Differences | PMHNP Boards

💎 Try Boss Pearl FREE for 7 days — the full library: every deep dive, the Diagnosing curriculum, and both books free the moment you're in — so you're ready for that first patient, not just studied for it. Then $20/month, cancel anytime: https://www.patreon.com/checkout/pearlsandprep?rid=29362056 🎁 Join as a free member to access 50 Pearls from Pearls & Prep — 50 super high-yield pearls to sharpen your practice. 📚 Members get both books free — Board Bombs: PMHNP 250 Questions ($49.99) and the 100 Psychiatric Interview Tips E-Book ($39.99). Not a member yet? Both are in the shop: https://www.patreon.com/c/pearlsandprep/shop ⭐ Enjoying the show? Please rate and review Pearls and Prep on Apple Podcasts or Spotify — it really helps! 🌐 PearlsandPrep.com — scan this episode's Street Takes card, read the deep-dive articles, and unlock the full clinical library: https://pearlsandprep.com ✉️ Questions or a case you want covered? Write to NP Z: pearlsandpreppodcast@gmail.com Venlafaxine versus duloxetine is not just another medication comparison — it is about which SNRI fits your patient's unique circumstances. This episode works through the psychopharmacology details that separate Effexor from Cymbalta, teaching you to choose based on clinical context rather than habit. You will gain the why behind SNRI selection and the clinical confidence to individualize treatment — exactly the reasoning PMHNP boards and real practice demand. 🎧 Pearls & Prep — new episodes every Tuesday. Hosted by NP Z, Duke-trained Psychiatric Nurse Practitioner. ⚖️ Disclaimer: Pearls and Prep is an educational podcast and is not medical advice. All views expressed are exclusively those of NP Z and do not represent — and are not endorsed by — any other entity or organization. These perspectives are offered solely to build conceptual appreciation of psychiatric topics; they are not a substitute for clinical judgment, current clinical guidelines, or primary references. Always use appropriate resources and your own clinical judgment when making decisions about individual patients. Nothing in this episode creates a clinician–patient relationship. 🎓 NP Z's Most Recommended Resources — Pass Your Boards & See Your First Patient The exact shelf behind this podcast: the textbooks open on NP Z's desk, and his own BOARD BOMBS™ + Interview Tips. 👉 pearlsandprep.com/resources Your board date is already on the calendar, and your first patient is already on someone's schedule. Build the shelf they're both counting on — start today.

• Transcript
• Chapters

Psychiatric Interview Skills: 4 Techniques for New PMHNPs | PMHNP Boards

💎 Try Boss Pearl FREE for 7 days — the full library: every deep dive, the Diagnosing curriculum, and both books free the moment you're in — so you're ready for that first patient, not just studied for it. Then $20/month, cancel anytime: https://www.patreon.com/checkout/pearlsandprep?rid=29362056 🎁 Join as a free member to access 50 Pearls from Pearls & Prep — 50 super high-yield pearls to sharpen your practice. 📚 Members get both books free — Board Bombs: PMHNP 250 Questions ($49.99) and the 100 Psychiatric Interview Tips E-Book ($39.99). Not a member yet? Both are in the shop: https://www.patreon.com/c/pearlsandprep/shop ⭐ Enjoying the show? Please rate and review Pearls and Prep on Apple Podcasts or Spotify — it really helps! 🌐 PearlsandPrep.com — scan this episode's Street Takes card, read the deep-dive articles, and unlock the full clinical library: https://pearlsandprep.com ✉️ Questions or a case you want covered? Write to NP Z: pearlsandpreppodcast@gmail.com Four psychiatric interview techniques every new PMHNP needs for evaluations that are smoother, more organized, and more human. Learn to run a structured psychiatric intake, build genuine therapeutic rapport, recognize the clinical clues that matter, and ask sharper questions. This episode gives you the why behind expert interviewing — not scripts, but reasoning — building the clinical confidence to walk into any evaluation prepared. Foundational PMHNP boards and early-career preparation. 🎧 Pearls & Prep — new episodes every Tuesday. Hosted by NP Z, Duke-trained Psychiatric Nurse Practitioner. ⚖️ Disclaimer: Pearls and Prep is an educational podcast and is not medical advice. All views expressed are exclusively those of NP Z and do not represent — and are not endorsed by — any other entity or organization. These perspectives are offered solely to build conceptual appreciation of psychiatric topics; they are not a substitute for clinical judgment, current clinical guidelines, or primary references. Always use appropriate resources and your own clinical judgment when making decisions about individual patients. Nothing in this episode creates a clinician–patient relationship. 🎓 NP Z's Most Recommended Resources — Pass Your Boards & See Your First Patient The exact shelf behind this podcast: the textbooks open on NP Z's desk, and his own BOARD BOMBS™ + Interview Tips. 👉 pearlsandprep.com/resources Your board date is already on the calendar, and your first patient is already on someone's schedule. Build the shelf they're both counting on — start today.

• Transcript
• Chapters

Long-Acting Injectables (LAIs) in Psychiatry: Benefits Explained | PMHNP Boards

💎 Try Boss Pearl FREE for 7 days — the full library: every deep dive, the Diagnosing curriculum, and both books free the moment you're in — so you're ready for that first patient, not just studied for it. Then $20/month, cancel anytime: https://www.patreon.com/checkout/pearlsandprep?rid=29362056 🎁 Join as a free member to access 50 Pearls from Pearls & Prep — 50 super high-yield pearls to sharpen your practice. 📚 Members get both books free — Board Bombs: PMHNP 250 Questions ($49.99) and the 100 Psychiatric Interview Tips E-Book ($39.99). Not a member yet? Both are in the shop: https://www.patreon.com/c/pearlsandprep/shop ⭐ Enjoying the show? Please rate and review Pearls and Prep on Apple Podcasts or Spotify — it really helps! 🌐 PearlsandPrep.com — scan this episode's Street Takes card, read the deep-dive articles, and unlock the full clinical library: https://pearlsandprep.com ✉️ Questions or a case you want covered? Write to NP Z: pearlsandpreppodcast@gmail.com Long-acting injectables bypass first-pass metabolism and day-to-day GI absorption variability, making them more reliable and predictable — with steadier plasma levels, smoother exposure, and no daily pill burden. This episode explains the psychopharmacology behind why LAIs work so well and when to consider them, giving you the why that transforms adherence conversations. You will build clinical confidence around one of psychiatry's most underused tools. Essential PMHNP boards prep on a true practice game-changer. 🎧 Pearls & Prep — new episodes every Tuesday. Hosted by NP Z, Duke-trained Psychiatric Nurse Practitioner. ⚖️ Disclaimer: Pearls and Prep is an educational podcast and is not medical advice. All views expressed are exclusively those of NP Z and do not represent — and are not endorsed by — any other entity or organization. These perspectives are offered solely to build conceptual appreciation of psychiatric topics; they are not a substitute for clinical judgment, current clinical guidelines, or primary references. Always use appropriate resources and your own clinical judgment when making decisions about individual patients. Nothing in this episode creates a clinician–patient relationship. 🎓 NP Z's Most Recommended Resources — Pass Your Boards & See Your First Patient The exact shelf behind this podcast: the textbooks open on NP Z's desk, and his own BOARD BOMBS™ + Interview Tips. 👉 pearlsandprep.com/resources Your board date is already on the calendar, and your first patient is already on someone's schedule. Build the shelf they're both counting on — start today.

• Transcript
• Chapters

False Positive Drug Screens: What Psychiatric Providers Must Know | PMHNP Boards

💎 Try Boss Pearl FREE for 7 days — the full library: every deep dive, the Diagnosing curriculum, and both books free the moment you're in — so you're ready for that first patient, not just studied for it. Then $20/month, cancel anytime: https://www.patreon.com/checkout/pearlsandprep?rid=29362056 🎁 Join as a free member to access 50 Pearls from Pearls & Prep — 50 super high-yield pearls to sharpen your practice. 📚 Members get both books free — Board Bombs: PMHNP 250 Questions ($49.99) and the 100 Psychiatric Interview Tips E-Book ($39.99). Not a member yet? Both are in the shop: https://www.patreon.com/c/pearlsandprep/shop ⭐ Enjoying the show? Please rate and review Pearls and Prep on Apple Podcasts or Spotify — it really helps! 🌐 PearlsandPrep.com — scan this episode's Street Takes card, read the deep-dive articles, and unlock the full clinical library: https://pearlsandprep.com ✉️ Questions or a case you want covered? Write to NP Z: pearlsandpreppodcast@gmail.com A false positive drug screen can derail a patient's entire treatment plan. Through mock patient Jimmy's story, this episode shows how a positive benzodiazepine screen upended the life of someone who was never taking benzodiazepines — and pinpoints exactly where the miscommunication happened. You will learn the clinical reasoning that prevents these errors, understanding the why behind confirmatory testing. High-yield PMHNP boards prep that builds the clinical confidence to protect patients from a lab result gone wrong. 🎧 Pearls & Prep — new episodes every Tuesday. Hosted by NP Z, Duke-trained Psychiatric Nurse Practitioner. ⚖️ Disclaimer: Pearls and Prep is an educational podcast and is not medical advice. All views expressed are exclusively those of NP Z and do not represent — and are not endorsed by — any other entity or organization. These perspectives are offered solely to build conceptual appreciation of psychiatric topics; they are not a substitute for clinical judgment, current clinical guidelines, or primary references. Always use appropriate resources and your own clinical judgment when making decisions about individual patients. Nothing in this episode creates a clinician–patient relationship. 🎓 NP Z's Most Recommended Resources — Pass Your Boards & See Your First Patient The exact shelf behind this podcast: the textbooks open on NP Z's desk, and his own BOARD BOMBS™ + Interview Tips. 👉 pearlsandprep.com/resources Your board date is already on the calendar, and your first patient is already on someone's schedule. Build the shelf they're both counting on — start today.

• Transcript
• Chapters

ADHD vs Bipolar Disorder: Key Questions for Differential Diagnosis | PMHNP Boards

💎 Try Boss Pearl FREE for 7 days — the full library: every deep dive, the Diagnosing curriculum, and both books free the moment you're in — so you're ready for that first patient, not just studied for it. Then $20/month, cancel anytime: https://www.patreon.com/checkout/pearlsandprep?rid=29362056 🎁 Join as a free member to access 50 Pearls from Pearls & Prep — 50 super high-yield pearls to sharpen your practice. 📚 Members get both books free — Board Bombs: PMHNP 250 Questions ($49.99) and the 100 Psychiatric Interview Tips E-Book ($39.99). Not a member yet? Both are in the shop: https://www.patreon.com/c/pearlsandprep/shop ⭐ Enjoying the show? Please rate and review Pearls and Prep on Apple Podcasts or Spotify — it really helps! 🌐 PearlsandPrep.com — scan this episode's Street Takes card, read the deep-dive articles, and unlock the full clinical library: https://pearlsandprep.com ✉️ Questions or a case you want covered? Write to NP Z: pearlsandpreppodcast@gmail.com Through mock patient Debbie's whirlwind of symptoms, this case study reveals how ADHD and bipolar disorder can mimic each other — and why getting it wrong can trigger a manic episode. Learn the specific questions that actually separate the two, grounded in DSM-5-TR differential diagnosis reasoning. This episode teaches the why behind each diagnostic clue, building the clinical confidence to navigate one of psychiatry's highest-stakes distinctions. Critical PMHNP boards prep for every prescriber. 🎧 Pearls & Prep — new episodes every Tuesday. Hosted by NP Z, Duke-trained Psychiatric Nurse Practitioner. ⚖️ Disclaimer: Pearls and Prep is an educational podcast and is not medical advice. All views expressed are exclusively those of NP Z and do not represent — and are not endorsed by — any other entity or organization. These perspectives are offered solely to build conceptual appreciation of psychiatric topics; they are not a substitute for clinical judgment, current clinical guidelines, or primary references. Always use appropriate resources and your own clinical judgment when making decisions about individual patients. Nothing in this episode creates a clinician–patient relationship. 🎓 NP Z's Most Recommended Resources — Pass Your Boards & See Your First Patient The exact shelf behind this podcast: the textbooks open on NP Z's desk, and his own BOARD BOMBS™ + Interview Tips. 👉 pearlsandprep.com/resources Your board date is already on the calendar, and your first patient is already on someone's schedule. Build the shelf they're both counting on — start today.

• Transcript
• Chapters